Insulin-like growth factor levels and chronic lymphocytic leukaemia: results from the MCC-Spain and EpiLymph-Spain studies

Abstract

Insulin‐like growth factor levels and chronic lymphocytic leukaemia


Spanish Ministry of Economy and Competitiveness–CarlosIII Institute of Health cofunded by FEDER funds/European Regional Develpment Fund (ERDF)–a way to build Europe (PI17/01280, PI11/01810, PI14/01219, PI11/02213, PI15/00966, RCESP C03/09, RTICESP C03/10, RTIC RD06/0020/0095, RD12/0036/0056, Rio Hortega CM13/00232, SV-09-CLINIC-1, CIBERESP and SAF2016-79347-R) and the Agència de Gestió d’Ajuts Universitaris i de Recerca AGAUR(2017SGR1085, 2014SGR756). The ICGC CLL-Genome Project was funded by Spanish Ministerio de Economía y Competitividad (MINECO) through the Instituto de Salud CarlosIII (ISCIII), PMP15/00007 and CIBERONC

Document Type

Article


Accepted version


peer-reviewed

Language

English

Publisher

Elsevier

Related items

info:eu-repo/semantics/altIdentifier/doi/10.1111/bjh.15583

info:eu-repo/semantics/altIdentifier/issn/0007-1048

info:eu-repo/semantics/altIdentifier/eissn/1365-2141

Recommended citation

This citation was generated automatically.

Rights

Tots els drets reservats. This is the peer reviewed version of the following article: Casabonne D, Benavente Y, Costas L, Robles C, Gonzalez-Barca E, de la Banda E. et al. Insulin-like growth factor levels and chronic lymphocytic leukaemia: results from the MCC-Spain and EpiLymph-Spain studies. Br J Haematol. 2019 May;185(3):608-612, which has been published in final form at http://dx.doi.org/10.1111/bjh.15583. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions

This item appears in the following Collection(s)